Drugs & Targets Zykadia gets first-line ALK-positive metastatic NSCLC indication June 02, 2017Vol.43 No.22
Drugs & Targets Advaxis and BMS announce collaboration focused on metastatic cervical cancer June 02, 2017Vol.43 No.22
Drugs & Targets FDA grants regular, accelerated approvals to Keytruda for urothelial carcinoma June 01, 2017Vol.40 No.05
Drugs & TargetsFree Keytruda gets accelerated approval based on a genetic feature—first such action May 26, 2017Vol.43 No.21
Drugs & TargetsFree Debiopharm acquires antibody-drug conjugate compound from ImmunoGen May 26, 2017Vol.43 No.21
Drugs & Targets FDA grants regular, accelerated approvals to Keytruda for urothelial carcinoma May 19, 2017Vol.43 No.20
